Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

ANIP holding history

Ani Pharmaceuticals Inc in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ANIP overviewAll 13F holders of ANIPFull Q2 2026 holdings

Shares (Q2 2026)
297,539
Value
$24.6M
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of ANIP by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026297,539$24.6M<0.1%−200,163−40.2%ReducedHolders
Q1 2026497,702$38.3M<0.1%+346,923+230.1%AddedHolders
Q4 2025150,779$11.9M<0.1%−439,095−74.4%ReducedHolders
Q3 2025589,874$54.0M<0.1%+185,172+45.8%AddedHolders
Q2 2025404,702$26.4M<0.1%+140,312+53.1%AddedHolders
Q1 2025264,390$17.7M<0.1%−330,420−55.6%ReducedHolders
Q4 2024594,810$32.9M<0.1%+308,322+107.6%AddedHolders
Q3 2024286,488$17.1M<0.1%+254,514+796.0%AddedHolders
Q2 202431,974$2.04M<0.1%+14,512+83.1%AddedHolders
Q1 202417,462$1.21M<0.1%−1,569−8.2%ReducedHolders
Q4 202319,031$1.05M<0.1%+12,853+208.0%AddedHolders
Q3 20236,178$358.7K<0.1%−25,895−80.7%ReducedHolders
Q2 202332,073$1.73M<0.1%+20,376+174.2%AddedHolders
Q1 202311,697$464.6K<0.1%+4,880+71.6%AddedHolders
Q4 20226,817$274.2K<0.1%+6,773+15,393.2%AddedHolders
Q3 202244$1.00K<0.1%+44NewHolders
Q2 20220$00.0%−481−100.0%Sold outHolders
Q1 2022481$14.0K<0.1%−5,420−91.8%ReducedHolders
Q4 20215,901$273.0K<0.1%+4,274+262.7%AddedHolders
Q3 20211,627$53.0K<0.1%−733−31.1%ReducedHolders
Q2 20212,360$83.0K<0.1%−1,603−40.4%ReducedHolders
Q1 20213,963$144.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.